APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Coagulation Factor Concentrate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Coagulation Factor Concentrate Market Analysis and Forecast 2026-2032

30 December 2025207 pages

Choose your research edition.

Industry ResearchRecombinant Coagulation Factor Concentrate Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Coagulation Factor Concentrate Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Recombinant Coagulation Factor Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Coagulation Factor Concentrate Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Coagulation Factor Concentrate Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Recombinant Coagulation Factor Concentrate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Coagulation Factor Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Coagulation Factor Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Coagulation Factor Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Coagulation Factor Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant Coagulation Factor Concentrate include Baxalta, Benefix, Idelvion, Lxinity, Novo Disk, Rebinyn, Rixubis, Biogen and Baxter, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Coagulation Factor Concentrate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Coagulation Factor Concentrate, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Coagulation Factor Concentrate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Coagulation Factor Concentrate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Coagulation Factor Concentrate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Coagulation Factor Concentrate sales, projected growth trends, production technology, application and end-user industry.

Recombinant Coagulation Factor Concentrate Segment by Company

Baxalta

Benefix

Idelvion

Lxinity

Novo Disk

Rebinyn

Rixubis

Biogen

Baxter

Bayer

Beijing Tiantan Biological Products

HUALAN BIOLOGICAL ENGINEERING

Pfizer

Wyeth

CSL

Green Cross

Alprolix

Sanofi

SHANGHAI RAAS

Taibang Biologic Group

Recombinant Coagulation Factor Concentrate Segment by Type

500IU

250IU

2000IU

1000IU

Recombinant Coagulation Factor Concentrate Segment by Application

Hopistial

Clinic

Others

Recombinant Coagulation Factor Concentrate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Coagulation Factor Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Coagulation Factor Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Coagulation Factor Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant Coagulation Factor Concentrate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant Coagulation Factor Concentrate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Coagulation Factor Concentrate sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 500IU Major Manufacturers Table 3. 250IU Major Manufacturers Table 4. 2000IU Major Manufacturers Table 5. 1000IU Major Manufacturers Table 6. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hopistial Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Recombinant Coagulation Factor Concentrate Industry Trends Table 11. Recombinant Coagulation Factor Concentrate Industry Drivers Table 12. Recombinant Coagulation Factor Concentrate Industry Opportunities and Challenges Table 13. Recombinant Coagulation Factor Concentrate Industry Restraints Table 14. Global Recombinant Coagulation Factor Concentrate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2021-2026) Table 18. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2027-2032) Table 19. Global Recombinant Coagulation Factor Concentrate Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Recombinant Coagulation Factor Concentrate Sales by Region (2021-2026) & (K Units) Table 21. Global Recombinant Coagulation Factor Concentrate Sales by Region (2027-2032) & (K Units) Table 22. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2021-2026) Table 23. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2027-2032) Table 24. Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Recombinant Coagulation Factor Concentrate Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Manufacturers (2021-2026) Table 28. Global Recombinant Coagulation Factor Concentrate Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Recombinant Coagulation Factor Concentrate Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Recombinant Coagulation Factor Concentrate Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Recombinant Coagulation Factor Concentrate Manufacturers, Product Type & Application Table 32. Global Recombinant Coagulation Factor Concentrate Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Recombinant Coagulation Factor Concentrate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Recombinant Coagulation Factor Concentrate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Recombinant Coagulation Factor Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2021-2026) Table 39. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2027-2032) Table 40. Global Recombinant Coagulation Factor Concentrate Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Recombinant Coagulation Factor Concentrate Sales by Type (2021-2026) & (K Units) Table 42. Global Recombinant Coagulation Factor Concentrate Sales by Type (2027-2032) & (K Units) Table 43. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2021-2026) Table 44. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2027-2032) Table 45. Global Recombinant Coagulation Factor Concentrate Price by Type (2021-2026) & (US$/Unit) Table 46. Global Recombinant Coagulation Factor Concentrate Price by Type (2027-2032) & (US$/Unit) Table 47. Global Recombinant Coagulation Factor Concentrate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Recombinant Coagulation Factor Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2021-2026) Table 51. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2027-2032) Table 52. Global Recombinant Coagulation Factor Concentrate Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Recombinant Coagulation Factor Concentrate Sales by Application (2021-2026) & (K Units) Table 54. Global Recombinant Coagulation Factor Concentrate Sales by Application (2027-2032) & (K Units) Table 55. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2021-2026) Table 56. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2027-2032) Table 57. Global Recombinant Coagulation Factor Concentrate Price by Application (2021-2026) & (US$/Unit) Table 58. Global Recombinant Coagulation Factor Concentrate Price by Application (2027-2032) & (US$/Unit) Table 59. Baxalta Company Information Table 60. Baxalta Business Overview Table 61. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Baxalta Recombinant Coagulation Factor Concentrate Product Portfolio Table 63. Baxalta Recent Development Table 64. Benefix Company Information Table 65. Benefix Business Overview Table 66. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Benefix Recombinant Coagulation Factor Concentrate Product Portfolio Table 68. Benefix Recent Development Table 69. Idelvion Company Information Table 70. Idelvion Business Overview Table 71. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Idelvion Recombinant Coagulation Factor Concentrate Product Portfolio Table 73. Idelvion Recent Development Table 74. Lxinity Company Information Table 75. Lxinity Business Overview Table 76. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Lxinity Recombinant Coagulation Factor Concentrate Product Portfolio Table 78. Lxinity Recent Development Table 79. Novo Disk Company Information Table 80. Novo Disk Business Overview Table 81. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Novo Disk Recombinant Coagulation Factor Concentrate Product Portfolio Table 83. Novo Disk Recent Development Table 84. Rebinyn Company Information Table 85. Rebinyn Business Overview Table 86. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Rebinyn Recombinant Coagulation Factor Concentrate Product Portfolio Table 88. Rebinyn Recent Development Table 89. Rixubis Company Information Table 90. Rixubis Business Overview Table 91. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Rixubis Recombinant Coagulation Factor Concentrate Product Portfolio Table 93. Rixubis Recent Development Table 94. Biogen Company Information Table 95. Biogen Business Overview Table 96. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Biogen Recombinant Coagulation Factor Concentrate Product Portfolio Table 98. Biogen Recent Development Table 99. Baxter Company Information Table 100. Baxter Business Overview Table 101. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Baxter Recombinant Coagulation Factor Concentrate Product Portfolio Table 103. Baxter Recent Development Table 104. Bayer Company Information Table 105. Bayer Business Overview Table 106. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Bayer Recombinant Coagulation Factor Concentrate Product Portfolio Table 108. Bayer Recent Development Table 109. Beijing Tiantan Biological Products Company Information Table 110. Beijing Tiantan Biological Products Business Overview Table 111. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product Portfolio Table 113. Beijing Tiantan Biological Products Recent Development Table 114. HUALAN BIOLOGICAL ENGINEERING Company Information Table 115. HUALAN BIOLOGICAL ENGINEERING Business Overview Table 116. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product Portfolio Table 118. HUALAN BIOLOGICAL ENGINEERING Recent Development Table 119. Pfizer Company Information Table 120. Pfizer Business Overview Table 121. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Pfizer Recombinant Coagulation Factor Concentrate Product Portfolio Table 123. Pfizer Recent Development Table 124. Wyeth Company Information Table 125. Wyeth Business Overview Table 126. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Wyeth Recombinant Coagulation Factor Concentrate Product Portfolio Table 128. Wyeth Recent Development Table 129. CSL Company Information Table 130. CSL Business Overview Table 131. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. CSL Recombinant Coagulation Factor Concentrate Product Portfolio Table 133. CSL Recent Development Table 134. Green Cross Company Information Table 135. Green Cross Business Overview Table 136. Green Cross Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Green Cross Recombinant Coagulation Factor Concentrate Product Portfolio Table 138. Green Cross Recent Development Table 139. Alprolix Company Information Table 140. Alprolix Business Overview Table 141. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Alprolix Recombinant Coagulation Factor Concentrate Product Portfolio Table 143. Alprolix Recent Development Table 144. Sanofi Company Information Table 145. Sanofi Business Overview Table 146. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Sanofi Recombinant Coagulation Factor Concentrate Product Portfolio Table 148. Sanofi Recent Development Table 149. SHANGHAI RAAS Company Information Table 150. SHANGHAI RAAS Business Overview Table 151. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product Portfolio Table 153. SHANGHAI RAAS Recent Development Table 154. Taibang Biologic Group Company Information Table 155. Taibang Biologic Group Business Overview Table 156. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product Portfolio Table 158. Taibang Biologic Group Recent Development Table 159. North America Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 160. North America Recombinant Coagulation Factor Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 161. North America Recombinant Coagulation Factor Concentrate Sales by Type (2021-2026) & (K Units) Table 162. North America Recombinant Coagulation Factor Concentrate Sales by Type (2027-2032) & (K Units) Table 163. North America Recombinant Coagulation Factor Concentrate Sales Price by Type (2021-2026) & (US$/Unit) Table 164. North America Recombinant Coagulation Factor Concentrate Sales Price by Type (2027-2032) & (US$/Unit) Table 165. North America Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 166. North America Recombinant Coagulation Factor Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 167. North America Recombinant Coagulation Factor Concentrate Sales by Application (2021-2026) & (K Units) Table 168. North America Recombinant Coagulation Factor Concentrate Sales by Application (2027-2032) & (K Units) Table 169. North America Recombinant Coagulation Factor Concentrate Sales Price by Application (2021-2026) & (US$/Unit) Table 170. North America Recombinant Coagulation Factor Concentrate Sales Price by Application (2027-2032) & (US$/Unit) Table 171. North America Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. North America Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. North America Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. North America Recombinant Coagulation Factor Concentrate Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. North America Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 176. North America Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 177. North America Recombinant Coagulation Factor Concentrate Sales Price by Country (2021-2026) & (US$/Unit) Table 178. North America Recombinant Coagulation Factor Concentrate Sales Price by Country (2027-2032) & (US$/Unit) Table 179. United States Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 180. Canada Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 181. Europe Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Recombinant Coagulation Factor Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Recombinant Coagulation Factor Concentrate Sales by Type (2021-2026) & (K Units) Table 184. Europe Recombinant Coagulation Factor Concentrate Sales by Type (2027-2032) & (K Units) Table 185. Europe Recombinant Coagulation Factor Concentrate Sales Price by Type (2021-2026) & (US$/Unit) Table 186. Europe Recombinant Coagulation Factor Concentrate Sales Price by Type (2027-2032) & (US$/Unit) Table 187. Europe Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Recombinant Coagulation Factor Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Recombinant Coagulation Factor Concentrate Sales by Application (2021-2026) & (K Units) Table 190. Europe Recombinant Coagulation Factor Concentrate Sales by Application (2027-2032) & (K Units) Table 191. Europe Recombinant Coagulation Factor Concentrate Sales Price by Application (2021-2026) & (US$/Unit) Table 192. Europe Recombinant Coagulation Factor Concentrate Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Europe Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 197. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 198. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 199. Europe Recombinant Coagulation Factor Concentrate Sales Price by Country (2021-2026) & (US$/Unit) Table 200. Europe Recombinant Coagulation Factor Concentrate Sales Price by Country (2027-2032) & (US$/Unit) Table 201. Germany Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 202. France Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 203. U.K. Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 204. Italy Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 205. Netherlands Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 206. China Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 207. China Recombinant Coagulation Factor Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 208. China Recombinant Coagulation Factor Concentrate Sales by Type (2021-2026) & (K Units) Table 209. China Recombinant Coagulation Factor Concentrate Sales by Type (2027-2032) & (K Units) Table 210. China Recombinant Coagulation Factor Concentrate Sales Price by Type (2021-2026) & (US$/Unit) Table 211. China Recombinant Coagulation Factor Concentrate Sales Price by Type (2027-2032) & (US$/Unit) Table 212. China Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 213. China Recombinant Coagulation Factor Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 214. China Recombinant Coagulation Factor Concentrate Sales by Application (2021-2026) & (K Units) Table 215. China Recombinant Coagulation Factor Concentrate Sales by Application (2027-2032) & (K Units) Table 216. China Recombinant Coagulation Factor Concentrate Sales Price by Application (2021-2026) & (US$/Unit) Table 217. China Recombinant Coagulation Factor Concentrate Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 219. Asia Recombinant Coagulation Factor Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 220. Asia Recombinant Coagulation Factor Concentrate Sales by Type (2021-2026) & (K Units) Table 221. Asia Recombinant Coagulation Factor Concentrate Sales by Type (2027-2032) & (K Units) Table 222. Asia Recombinant Coagulation Factor Concentrate Sales Price by Type (2021-2026) & (US$/Unit) Table 223. Asia Recombinant Coagulation Factor Concentrate Sales Price by Type (2027-2032) & (US$/Unit) Table 224. Asia Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 225. Asia Recombinant Coagulation Factor Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 226. Asia Recombinant Coagulation Factor Concentrate Sales by Application (2021-2026) & (K Units) Table 227. Asia Recombinant Coagulation Factor Concentrate Sales by Application (2027-2032) & (K Units) Table 228. Asia Recombinant Coagulation Factor Concentrate Sales Price by Application (2021-2026) & (US$/Unit) Table 229. Asia Recombinant Coagulation Factor Concentrate Sales Price by Application (2027-2032) & (US$/Unit) Table 230. Asia Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. Asia Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. Asia Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. Asia Recombinant Coagulation Factor Concentrate Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 234. Asia Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 235. Asia Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 236. Asia Recombinant Coagulation Factor Concentrate Sales Price by Country (2021-2026) & (US$/Unit) Table 237. Asia Recombinant Coagulation Factor Concentrate Sales Price by Country (2027-2032) & (US$/Unit) Table 238. Japan Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 239. South Korea Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 240. India Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 241. Australia Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 242. China Taiwan Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 243. Southeast Asia Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 244. SAMEA Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2026) & (US$ Million) Table 245. SAMEA Recombinant Coagulation Factor Concentrate Revenue by Type (2027-2032) & (US$ Million) Table 246. SAMEA Recombinant Coagulation Factor Concentrate Sales by Type (2021-2026) & (K Units) Table 247. SAMEA Recombinant Coagulation Factor Concentrate Sales by Type (2027-2032) & (K Units) Table 248. SAMEA Recombinant Coagulation Factor Concentrate Sales Price by Type (2021-2026) & (US$/Unit) Table 249. SAMEA Recombinant Coagulation Factor Concentrate Sales Price by Type (2027-2032) & (US$/Unit) Table 250. SAMEA Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2026) & (US$ Million) Table 251. SAMEA Recombinant Coagulation Factor Concentrate Revenue by Application (2027-2032) & (US$ Million) Table 252. SAMEA Recombinant Coagulation Factor Concentrate Sales by Application (2021-2026) & (K Units) Table 253. SAMEA Recombinant Coagulation Factor Concentrate Sales by Application (2027-2032) & (K Units) Table 254. SAMEA Recombinant Coagulation Factor Concentrate Sales Price by Application (2021-2026) & (US$/Unit) Table 255. SAMEA Recombinant Coagulation Factor Concentrate Sales Price by Application (2027-2032) & (US$/Unit) Table 256. SAMEA Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 257. SAMEA Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 258. SAMEA Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 259. SAMEA Recombinant Coagulation Factor Concentrate Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 260. SAMEA Recombinant Coagulation Factor Concentrate Sales by Country (2021-2026) & (K Units) Table 261. SAMEA Recombinant Coagulation Factor Concentrate Sales by Country (2027-2032) & (K Units) Table 262. SAMEA Recombinant Coagulation Factor Concentrate Sales Price by Country (2021-2026) & (US$/Unit) Table 263. SAMEA Recombinant Coagulation Factor Concentrate Sales Price by Country (2027-2032) & (US$/Unit) Table 264. Brazil Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 265. Argentina Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 266. Chile Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 267. Colombia Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 268. Peru Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 269. Saudi Arabia Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 270. Israel Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 271. UAE Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 272. Turkey Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 273. Iran Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 274. Egypt Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Table 275. Key Raw Materials Table 276. Raw Materials Key Suppliers Table 277. Recombinant Coagulation Factor Concentrate Distributors List Table 278. Recombinant Coagulation Factor Concentrate Customers List Table 279. Research Programs/Design for This Report Table 280. Authors List of This Report Table 281. Secondary Sources Table 282. Primary Sources List of Figures Figure 1. Recombinant Coagulation Factor Concentrate Image Figure 2. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Coagulation Factor Concentrate Market Size Share 2021 VS 2025 VS 2032 Figure 4. 500IU Image Figure 5. 250IU Image Figure 6. 2000IU Image Figure 7. 1000IU Image Figure 8. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Recombinant Coagulation Factor Concentrate Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hopistial Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Recombinant Coagulation Factor Concentrate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Recombinant Coagulation Factor Concentrate Revenue (2021-2032) & (US$ Million) Figure 15. Global Recombinant Coagulation Factor Concentrate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2021-2032) Figure 18. Global Recombinant Coagulation Factor Concentrate Sales (2021-2032) & (K Units) Figure 19. Global Recombinant Coagulation Factor Concentrate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Recombinant Coagulation Factor Concentrate Sales YoY (2021-2032) & (K Units) Figure 22. Europe Recombinant Coagulation Factor Concentrate Sales YoY (2021-2032) & (K Units) Figure 23. China Recombinant Coagulation Factor Concentrate Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Recombinant Coagulation Factor Concentrate Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Recombinant Coagulation Factor Concentrate Sales YoY (2021-2032) & (K Units) Figure 26. Global Recombinant Coagulation Factor Concentrate Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Recombinant Coagulation Factor Concentrate Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Recombinant Coagulation Factor Concentrate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2021-2032) Figure 32. Global Recombinant Coagulation Factor Concentrate Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2021-2032) Figure 35. Global Recombinant Coagulation Factor Concentrate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2021-2032) Figure 38. Global Recombinant Coagulation Factor Concentrate Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2021-2032) Figure 41. North America Recombinant Coagulation Factor Concentrate Revenue Share by Type (2021-2032) Figure 42. North America Recombinant Coagulation Factor Concentrate Sales Share by Type (2021-2032) Figure 43. North America Recombinant Coagulation Factor Concentrate Revenue Share by Application (2021-2032) Figure 44. North America Recombinant Coagulation Factor Concentrate Sales Share by Application (2021-2032) Figure 45. North America Recombinant Coagulation Factor Concentrate Revenue Share by Country (2021-2032) Figure 46. North America Recombinant Coagulation Factor Concentrate Sales Share by Country (2021-2032) Figure 47. Europe Recombinant Coagulation Factor Concentrate Revenue Share by Type (2021-2032) Figure 48. Europe Recombinant Coagulation Factor Concentrate Sales Share by Type (2021-2032) Figure 49. Europe Recombinant Coagulation Factor Concentrate Revenue Share by Application (2021-2032) Figure 50. Europe Recombinant Coagulation Factor Concentrate Sales Share by Application (2021-2032) Figure 51. Europe Recombinant Coagulation Factor Concentrate Revenue Share by Country (2021-2032) Figure 52. Europe Recombinant Coagulation Factor Concentrate Sales Share by Country (2021-2032) Figure 53. China Recombinant Coagulation Factor Concentrate Revenue Share by Type (2021-2032) Figure 54. China Recombinant Coagulation Factor Concentrate Sales Share by Type (2021-2032) Figure 55. China Recombinant Coagulation Factor Concentrate Revenue Share by Application (2021-2032) Figure 56. China Recombinant Coagulation Factor Concentrate Sales Share by Application (2021-2032) Figure 57. Asia Recombinant Coagulation Factor Concentrate Revenue Share by Type (2021-2032) Figure 58. Asia Recombinant Coagulation Factor Concentrate Sales Share by Type (2021-2032) Figure 59. Asia Re

Scope & coverage.

Types
  • 500IU
  • 250IU
  • 2000IU
  • 1000IU
Applications
  • Hopistial
  • Clinic
  • Others
Companies covered
  • Baxalta
  • Benefix
  • Idelvion
  • Lxinity
  • Novo Disk
  • Rebinyn
  • Rixubis
  • Biogen
  • Baxter
  • Bayer
  • Beijing Tiantan Biological Products
  • HUALAN BIOLOGICAL ENGINEERING
  • Pfizer
  • Wyeth
  • CSL
  • Green Cross
  • Alprolix
  • Sanofi
  • SHANGHAI RAAS
  • Taibang Biologic Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Coagulation Factor Concentrate Market by Type
  3. 1.2.1 Global Recombinant Coagulation Factor Concentrate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 500IU
  5. 1.2.3 250IU
  6. 1.2.4 2000IU
  7. 1.2.5 1000IU
  8. 1.3 Recombinant Coagulation Factor Concentrate Market by Application
  9. 1.3.1 Global Recombinant Coagulation Factor Concentrate Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hopistial
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Recombinant Coagulation Factor Concentrate Market Dynamics
  1. 2.1 Recombinant Coagulation Factor Concentrate Industry Trends
  2. 2.2 Recombinant Coagulation Factor Concentrate Industry Drivers
  3. 2.3 Recombinant Coagulation Factor Concentrate Industry Opportunities and Challenges
  4. 2.4 Recombinant Coagulation Factor Concentrate Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant Coagulation Factor Concentrate Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant Coagulation Factor Concentrate Revenue by Region
  3. 3.2.1 Global Recombinant Coagulation Factor Concentrate Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Coagulation Factor Concentrate Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant Coagulation Factor Concentrate Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant Coagulation Factor Concentrate Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant Coagulation Factor Concentrate Sales by Region
  9. 3.4.1 Global Recombinant Coagulation Factor Concentrate Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant Coagulation Factor Concentrate Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant Coagulation Factor Concentrate Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturers
  2. 4.1.1 Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant Coagulation Factor Concentrate Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Coagulation Factor Concentrate Sales by Manufacturers
  6. 4.2.1 Global Recombinant Coagulation Factor Concentrate Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant Coagulation Factor Concentrate Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant Coagulation Factor Concentrate Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant Coagulation Factor Concentrate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant Coagulation Factor Concentrate Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant Coagulation Factor Concentrate Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant Coagulation Factor Concentrate Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant Coagulation Factor Concentrate Market CR5 and HHI
  16. 4.8.2 2025 Recombinant Coagulation Factor Concentrate Tier 1, Tier 2, and Tier 3
5 Recombinant Coagulation Factor Concentrate Market by Type
  1. 5.1 Global Recombinant Coagulation Factor Concentrate Revenue by Type
  2. 5.1.1 Global Recombinant Coagulation Factor Concentrate Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant Coagulation Factor Concentrate Sales by Type
  6. 5.2.1 Global Recombinant Coagulation Factor Concentrate Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant Coagulation Factor Concentrate Price by Type
6 Recombinant Coagulation Factor Concentrate Market by Application
  1. 6.1 Global Recombinant Coagulation Factor Concentrate Revenue by Application
  2. 6.1.1 Global Recombinant Coagulation Factor Concentrate Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant Coagulation Factor Concentrate Sales by Application
  6. 6.2.1 Global Recombinant Coagulation Factor Concentrate Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant Coagulation Factor Concentrate Price by Application
7 Company Profiles
  1. 7.1 Baxalta
  2. 7.1.1 Baxalta Company Information
  3. 7.1.2 Baxalta Business Overview
  4. 7.1.3 Baxalta Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Baxalta Recombinant Coagulation Factor Concentrate Product Portfolio
  6. 7.1.5 Baxalta Recent Developments
  7. 7.2 Benefix
  8. 7.2.1 Benefix Company Information
  9. 7.2.2 Benefix Business Overview
  10. 7.2.3 Benefix Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Benefix Recombinant Coagulation Factor Concentrate Product Portfolio
  12. 7.2.5 Benefix Recent Developments
  13. 7.3 Idelvion
  14. 7.3.1 Idelvion Company Information
  15. 7.3.2 Idelvion Business Overview
  16. 7.3.3 Idelvion Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Idelvion Recombinant Coagulation Factor Concentrate Product Portfolio
  18. 7.3.5 Idelvion Recent Developments
  19. 7.4 Lxinity
  20. 7.4.1 Lxinity Company Information
  21. 7.4.2 Lxinity Business Overview
  22. 7.4.3 Lxinity Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lxinity Recombinant Coagulation Factor Concentrate Product Portfolio
  24. 7.4.5 Lxinity Recent Developments
  25. 7.5 Novo Disk
  26. 7.5.1 Novo Disk Company Information
  27. 7.5.2 Novo Disk Business Overview
  28. 7.5.3 Novo Disk Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novo Disk Recombinant Coagulation Factor Concentrate Product Portfolio
  30. 7.5.5 Novo Disk Recent Developments
  31. 7.6 Rebinyn
  32. 7.6.1 Rebinyn Company Information
  33. 7.6.2 Rebinyn Business Overview
  34. 7.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Product Portfolio
  36. 7.6.5 Rebinyn Recent Developments
  37. 7.7 Rixubis
  38. 7.7.1 Rixubis Company Information
  39. 7.7.2 Rixubis Business Overview
  40. 7.7.3 Rixubis Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Rixubis Recombinant Coagulation Factor Concentrate Product Portfolio
  42. 7.7.5 Rixubis Recent Developments
  43. 7.8 Biogen
  44. 7.8.1 Biogen Company Information
  45. 7.8.2 Biogen Business Overview
  46. 7.8.3 Biogen Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biogen Recombinant Coagulation Factor Concentrate Product Portfolio
  48. 7.8.5 Biogen Recent Developments
  49. 7.9 Baxter
  50. 7.9.1 Baxter Company Information
  51. 7.9.2 Baxter Business Overview
  52. 7.9.3 Baxter Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Baxter Recombinant Coagulation Factor Concentrate Product Portfolio
  54. 7.9.5 Baxter Recent Developments
  55. 7.10 Bayer
  56. 7.10.1 Bayer Company Information
  57. 7.10.2 Bayer Business Overview
  58. 7.10.3 Bayer Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bayer Recombinant Coagulation Factor Concentrate Product Portfolio
  60. 7.10.5 Bayer Recent Developments
  61. 7.11 Beijing Tiantan Biological Products
  62. 7.11.1 Beijing Tiantan Biological Products Company Information
  63. 7.11.2 Beijing Tiantan Biological Products Business Overview
  64. 7.11.3 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product Portfolio
  66. 7.11.5 Beijing Tiantan Biological Products Recent Developments
  67. 7.12 HUALAN BIOLOGICAL ENGINEERING
  68. 7.12.1 HUALAN BIOLOGICAL ENGINEERING Company Information
  69. 7.12.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
  70. 7.12.3 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product Portfolio
  72. 7.12.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
  73. 7.13 Pfizer
  74. 7.13.1 Pfizer Company Information
  75. 7.13.2 Pfizer Business Overview
  76. 7.13.3 Pfizer Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Pfizer Recombinant Coagulation Factor Concentrate Product Portfolio
  78. 7.13.5 Pfizer Recent Developments
  79. 7.14 Wyeth
  80. 7.14.1 Wyeth Company Information
  81. 7.14.2 Wyeth Business Overview
  82. 7.14.3 Wyeth Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Wyeth Recombinant Coagulation Factor Concentrate Product Portfolio
  84. 7.14.5 Wyeth Recent Developments
  85. 7.15 CSL
  86. 7.15.1 CSL Company Information
  87. 7.15.2 CSL Business Overview
  88. 7.15.3 CSL Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 CSL Recombinant Coagulation Factor Concentrate Product Portfolio
  90. 7.15.5 CSL Recent Developments
  91. 7.16 Green Cross
  92. 7.16.1 Green Cross Company Information
  93. 7.16.2 Green Cross Business Overview
  94. 7.16.3 Green Cross Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Green Cross Recombinant Coagulation Factor Concentrate Product Portfolio
  96. 7.16.5 Green Cross Recent Developments
  97. 7.17 Alprolix
  98. 7.17.1 Alprolix Company Information
  99. 7.17.2 Alprolix Business Overview
  100. 7.17.3 Alprolix Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Alprolix Recombinant Coagulation Factor Concentrate Product Portfolio
  102. 7.17.5 Alprolix Recent Developments
  103. 7.18 Sanofi
  104. 7.18.1 Sanofi Company Information
  105. 7.18.2 Sanofi Business Overview
  106. 7.18.3 Sanofi Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Sanofi Recombinant Coagulation Factor Concentrate Product Portfolio
  108. 7.18.5 Sanofi Recent Developments
  109. 7.19 SHANGHAI RAAS
  110. 7.19.1 SHANGHAI RAAS Company Information
  111. 7.19.2 SHANGHAI RAAS Business Overview
  112. 7.19.3 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product Portfolio
  114. 7.19.5 SHANGHAI RAAS Recent Developments
  115. 7.20 Taibang Biologic Group
  116. 7.20.1 Taibang Biologic Group Company Information
  117. 7.20.2 Taibang Biologic Group Business Overview
  118. 7.20.3 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product Portfolio
  120. 7.20.5 Taibang Biologic Group Recent Developments
8 North America
  1. 8.1 North America Recombinant Coagulation Factor Concentrate Market Size by Type
  2. 8.1.1 North America Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant Coagulation Factor Concentrate Price by Type (2021-2032)
  5. 8.2 North America Recombinant Coagulation Factor Concentrate Market Size by Application
  6. 8.2.1 North America Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant Coagulation Factor Concentrate Price by Application (2021-2032)
  9. 8.3 North America Recombinant Coagulation Factor Concentrate Market Size by Country
  10. 8.3.1 North America Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant Coagulation Factor Concentrate Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant Coagulation Factor Concentrate Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Recombinant Coagulation Factor Concentrate Market Size by Type
  2. 9.1.1 Europe Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant Coagulation Factor Concentrate Price by Type (2021-2032)
  5. 9.2 Europe Recombinant Coagulation Factor Concentrate Market Size by Application
  6. 9.2.1 Europe Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant Coagulation Factor Concentrate Price by Application (2021-2032)
  9. 9.3 Europe Recombinant Coagulation Factor Concentrate Market Size by Country
  10. 9.3.1 Europe Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant Coagulation Factor Concentrate Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant Coagulation Factor Concentrate Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Recombinant Coagulation Factor Concentrate Market Size by Type
  2. 10.1.1 China Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant Coagulation Factor Concentrate Price by Type (2021-2032)
  5. 10.2 China Recombinant Coagulation Factor Concentrate Market Size by Application
  6. 10.2.1 China Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant Coagulation Factor Concentrate Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Coagulation Factor Concentrate Market Size by Type
  2. 11.1.1 Asia Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant Coagulation Factor Concentrate Price by Type (2021-2032)
  5. 11.2 Asia Recombinant Coagulation Factor Concentrate Market Size by Application
  6. 11.2.1 Asia Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant Coagulation Factor Concentrate Price by Application (2021-2032)
  9. 11.3 Asia Recombinant Coagulation Factor Concentrate Market Size by Country
  10. 11.3.1 Asia Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant Coagulation Factor Concentrate Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant Coagulation Factor Concentrate Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Coagulation Factor Concentrate Market Size by Type
  2. 12.1.1 SAMEA Recombinant Coagulation Factor Concentrate Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant Coagulation Factor Concentrate Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant Coagulation Factor Concentrate Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant Coagulation Factor Concentrate Market Size by Application
  6. 12.2.1 SAMEA Recombinant Coagulation Factor Concentrate Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant Coagulation Factor Concentrate Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant Coagulation Factor Concentrate Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant Coagulation Factor Concentrate Market Size by Country
  10. 12.3.1 SAMEA Recombinant Coagulation Factor Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant Coagulation Factor Concentrate Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant Coagulation Factor Concentrate Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant Coagulation Factor Concentrate Value Chain Analysis
  2. 13.1.1 Recombinant Coagulation Factor Concentrate Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant Coagulation Factor Concentrate Production Mode & Process
  6. 13.2 Recombinant Coagulation Factor Concentrate Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant Coagulation Factor Concentrate Distributors
  9. 13.2.3 Recombinant Coagulation Factor Concentrate Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst